Company Filing History:
Years Active: 2018-2022
Title: Feny Gunawan: Innovator in Biopharmaceuticals
Introduction
Feny Gunawan is a prominent inventor based in San Francisco, CA, known for his contributions to the field of biopharmaceuticals. He has been instrumental in developing innovative methods and compositions that enhance the detection and quantification of host cell proteins in cell lines and recombinant polypeptide products. With a total of three patents to his name, Gunawan continues to push the boundaries of scientific research.
Latest Patents
Feny Gunawan's latest patents focus on compositions and methods for detecting and quantifying hamster phospholipase B-like 2. These patents include monoclonal and polyclonal antibodies that specifically bind to this enzyme. Additionally, he has developed methods for detecting and quantifying hamster phospholipase B-like 2 in recombinant polypeptide preparations. His work also encompasses kits designed for these detection methods, as well as techniques for screening host cell lines that express low levels of this enzyme.
Career Highlights
Gunawan is currently employed at Genentech, Inc., a leading biotechnology company. His role involves significant research and development efforts aimed at improving biopharmaceutical products. His innovative approaches have contributed to advancements in the industry, particularly in the area of protein quantification.
Collaborations
Feny Gunawan collaborates with several esteemed colleagues, including Yi-Chun Hsiao and Denise C Krawitz. These partnerships enhance the research environment and foster the exchange of ideas, leading to groundbreaking discoveries in their field.
Conclusion
Feny Gunawan is a key figure in the biopharmaceutical industry, with a focus on innovative methods for protein detection and quantification. His contributions through patents and collaborations continue to impact the field positively.